アジア太平洋地域の幹細胞製造市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2021 –2028 |
 市場規模（基準年） |
USD 11,076.78 Million |
 Market Size (Forecast Year) |
USD 23,505.08 Million |
 CAGR |
% |
| 主要市場プレーヤー |
>アジア太平洋の幹細胞製造市場、製品別（幹細胞株、器具、消耗品、キット）、用途別（研究用途、臨床用途、細胞および組織バンキングなど）、エンドユーザー別（バイオテクノロジーおよび製薬会社、研究機関および学術機関、細胞バンクおよび組織バンク、病院および外科センターなど）、流通チャネル別（直接販売およびサードパーティ販売代理店）、国別（日本、中国、オーストラリア、韓国、インド、シンガポール、タイ、インドネシア、マレーシア、フィリピン、その他のアジア太平洋地域）。2028年までの業界動向と予測。
市場分析と洞察: アジア太平洋地域の幹細胞製造市場
アジア太平洋地域の幹細胞製造市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に10.1％のCAGRで成長し、2020年の110億7,678万米ドルから2028年には235億508万米ドルに達すると分析しています。がんや幹細胞移植の罹患率の上昇、幹細胞移植に関する新たな技術進歩の成長は、予測期間における市場の需要を推進する主要な原動力となる可能性があります。
幹細胞は、さまざまな細胞に分化できる体の原材料です。つまり、特殊な機能を持つ他のすべての細胞が生成される細胞です。幹細胞療法は、同種療法および自己療法のための胚性幹細胞、成体幹細胞を含むあらゆる種類のヒト幹細胞を使用する病状の治療として定義されます。
幹細胞研究の出現により、幹細胞とその誘導体の治療効果が明らかになりました。幹細胞とその誘導体の製造の成功は、ヘルスケアの分野にプラスの影響を与えています。これらの幹細胞製品は、損傷した組織や臓器の機能を回復し、がん、血液疾患、遺伝性疾患、自己免疫疾患、炎症性疾患の治療のための幹細胞ベースの細胞療法を開発するために使用されます。
革新的な製品の開発に向けた主要な業界プレーヤーによる研究開発の増加、政府による支援、幹細胞の採用の増加が、市場の成長を牽引しています。この分野に存在する高度な方法論も、世界の幹細胞製造市場の成長を促進しています。ただし、治療費の高さ、腫瘍治療の代替手段の可用性が市場を抑制する可能性があります。多数のパイプライン製品の存在と、市場プレーヤーによる戦略的イニシアチブは、市場にとってチャンスとなっています。熟練した専門家の不足は、市場にとって課題となる可能性があります。
世界の幹細胞製造市場レポートでは、市場シェア、新しい開発、国内および現地の市場プレーヤーの影響の詳細を提供し、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から機会を分析します。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、収益に影響を与えるソリューションを作成し、希望する目標を達成できるようお手伝いします。
世界の幹細胞製造市場の範囲と市場規模
アジア太平洋地域の幹細胞製造市場は、製品、アプリケーション、エンドユーザー、流通チャネルに基づいて 4 つの主要なセグメントに分類されています。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
- 製品に基づいて、幹細胞製造市場は幹細胞株、機器、消耗品およびキットに分類されます。2021年には、消耗品の頻繁な購入、幹細胞研究の増加、幹細胞治療の需要の増加により、消耗品およびキットセグメントが市場を支配すると予想されます。
- アプリケーションに基づいて、幹細胞製造市場は、研究アプリケーション、臨床アプリケーション、細胞および組織バンキング、その他に分類されます。 2021年には、幹細胞細胞学および病態生理学研究への注目が高まり、幹細胞製品の開発と商業化を支援するための官民資金が増加しているため、研究アプリケーションセグメントが市場を支配すると予想されます。
- エンドユーザーに基づいて、幹細胞製造市場は、バイオテクノロジーおよび製薬会社、研究機関および学術機関、細胞バンクおよび組織バンク、病院および外科センター、その他に分類されます。 2021年には、製薬会社およびバイオテクノロジー会社による幹細胞研究の能力拡大に向けた戦略的取り組み（買収、パートナーシップ、コラボレーションなど）の重要性が高まっているため、製薬会社およびバイオテクノロジー会社セグメントが市場を支配すると予想されます。
- 流通チャネルに基づいて、幹細胞製造市場は直接販売とサードパーティの販売代理店に分割されます。 2021年には、市場に多数のプレーヤーが存在するため、直接販売セグメントが市場を支配すると予想されます。
アジア太平洋地域の幹細胞製造市場の国別分析
幹細胞製造市場が分析され、製品、アプリケーション、エンドユーザー、流通チャネル別に市場規模の情報が提供されます。
幹細胞製造市場レポートで取り上げられている国は、中国、日本、インド、オーストラリア、韓国、シンガポール、タイ、マレーシア、インドネシア、フィリピン、ベトナム、その他のアジア太平洋地域 (APAC) です。
中国は、幹細胞に基づく治療と先進技術の採用に関する認識の高まりにより、アジア太平洋地域における世界の幹細胞製造市場を支配しています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
幹細胞療法の採用拡大と官民資金の投入により、世界の幹細胞製造市場にチャンスが生まれています。
幹細胞製造市場では、創傷デブリードマン装置の売上、ELISpot および FluorSpot アッセイの進歩の影響、ELISpot および FluorSpot アッセイ市場へのサポートに関する規制シナリオの変化など、各国の特定産業の成長に関する詳細な市場分析も提供されます。データは 2019 年から 2020 年の履歴期間について利用可能です。
競争環境と幹細胞製造市場シェア分析
幹細胞製造市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、幹細胞製造市場に関連する会社の焦点にのみ関連しています。
幹細胞製造を提供する主要企業としては、Thermo Fisher Scientific Inc.、Merck KGaA、BD、Organogenesis Inc.、Vericel Corporation、ANTEROGEN. CO., LTD.、VistaGen Therapeutics, Inc.、FUJIFILM Cellular Dynamics, Inc.、American CryoSystem Corporation、PromoCell GmbH、Sartorius AG、ViaCyte, Inc.、STEM CELL Technologies, Inc.、武田薬品工業株式会社、第一三共株式会社、Bio-Techne、REPROCELL Inc.、Catalent, Inc、Mesoblast Ltd、アステラス製薬株式会社などがあります。
市場プレーヤーによる戦略的取り組みと幹細胞製造における新たな技術進歩により、さまざまな治療法のギャップが埋められています。
例えば、
- 2021年6月、REPROCELL Inc.は、iPSC由来のマスター細胞バンクの需要増加に対応するため、新しいシードiPSC製造スイートを開設したことを発表しました。これにより、同社は今後数年間で高まる需要に対応し、成長することができます。
- 2021年6月、Catalent Inc.は、ヒト人工多能性幹細胞の製造業者であるRheinCell Therapeuicsを買収したことを発表しました。これにより、同社は既存のカスタム細胞治療プロセス開発を強化することができます。
- 2021年6月、バイオテクネは遺伝子工学および細胞・遺伝子治療の製造能力を強化したと発表しました。これにより、同社はさらに事業を拡大することができます。
市場プレーヤーによるコラボレーション、ジョイントベンチャー、およびその他の戦略により、幹細胞製造市場における企業市場が強化され、組織が幹細胞製造市場向けの提供を改善するメリットももたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: REGULATIONS
5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
5.2 REGULATORY FRAMEWORK IN EUROPE
5.3 REGULATORY FRAMEWORK IN INDIA
5.4 REGULATORY FRAMEWORK IN JAPAN
6 PESTEL ANALYSIS
7 PORTERS FIVE FORCES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CANCER
8.1.2 INCREASE INVESTMENT IN R & D
8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
8.2 RESTRAINTS
8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
8.3 OPPORTUNITIES
8.3.1 PRESENCE OF PIPELINE PRODUCTS
8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 IMPACT OF COVID-19 ON ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY
9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
9.5 CONCLUSION
10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 CONSUMABLES & KITS
10.2.1 CULTURE MEDIA
10.2.2 DIFFERENTIATION KITS
10.2.3 STEM CELL ANTIBODY ARRAYS
10.2.4 IDENTIFICATION KITS
10.2.5 STEM CELL ANTIBODY PANELS
10.2.6 STEM CELL PRIMER PAIR PANELS
10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
10.2.9 OTHERS
10.3 STEM CELL LINES
10.3.1 HUMAN CELL SYSTEMS
10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
10.3.1.2 MESENCHYMAL STEM CELLS
10.3.1.3 PRIMARY HUMAN CELLS
10.3.1.3.1 FIBROBLAST
10.3.1.3.2 EPITHELIAL
10.3.1.3.3 ENDOTHELIAL
10.3.1.4 HEMATOPOIETIC STEM CELLS
10.3.1.5 NEURAL STEM CELLS
10.3.1.6 CARDIAC STEM CELLS
10.3.1.7 PANCREATIC STEM CELLS
10.3.1.8 OTHERS
10.3.2 RODENT CELL SYSTEMS
10.3.2.1 PLURIPOTENT MOUSE ES CELLS
10.3.2.2 MOUSE EMBRYO CULTURE
10.3.2.3 PMEFS
10.3.2.4 MULTIPOTENT RODENT STEM CELLS
10.3.2.5 MESENCHYMAL STEM CELLS
10.3.2.6 NEURAL STEM CELLS
10.3.2.7 OTHERS
10.4 INSTRUMENTS
10.4.1 BIOREACTORS & INCUBATORS
10.4.2 CELL SORTERS
10.4.3 OTHERS
11 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 RESEARCH APPLICATIONS
11.2.1 LIFE SCIENCE RESEARCH
11.2.2 DRUG DISCOVERY AND DEVELOPMENT
11.3 CLINICAL APPLICATIONS
11.3.1 ALLOGENIC STEM CELL THERAPY
11.3.1.1 SURGERIES
11.3.1.2 MUSCULOSKELETAL DISORDERS
11.3.1.3 WOUNDS AND INJURIES
11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
11.3.1.5 OTHERS
11.3.2 AUTOLOGOUS STEM CELL THERAPY
11.3.2.1 WOUNDS & INJURIES
11.3.2.2 CARDIOVASCULAR DISEASES
11.3.2.3 GASTROINTESTINAL DISEASES
11.3.2.4 OTHERS
11.4 CELL & TISSUE BANKING
11.5 OTHERS
12 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER
12.1 OVERVIEW
12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
12.4 CELL BANKS & TISSUE BANKS
12.5 HOSPITALS & SURGICAL CENTERS
12.6 OTHERS
13 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT SALES
13.3 THIRD PARTY DISTRIBUTORS
14 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY REGION
14.1 OVERVIEW
14.2 ASIA-PACIFIC
14.2.1 CHINA
14.2.2 JAPAN
14.2.3 SOUTH KOREA
14.2.4 AUSTRALIA
14.2.5 SINGAPORE
14.2.6 INDIA
14.2.7 THAILAND
14.2.8 MALAYSIA
14.2.9 INDONESIA
14.2.10 PHILIPPINES
14.2.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 AMERICAN CRYOSYSTEM CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 ANTEROGEN.CO.,LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ASTELLAS PHARMA INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 BD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 COMPANY SHARE ANALYSIS
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENT
17.8 BIO-TECHNE
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 CATALENT, INC
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 DAIICHI SANKYO COMPANY, LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 FUJIFILM CELLULAR DYNAMICS, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 COMPANY SHARE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 MESOBLAST LTD
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 ORGANOGENESIS INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 PROMOCELL GMBH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 REPROCELL INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SARTORIUS AG
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 STEMCELL TECHNOLOGIES INC.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 VERICEL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 VIACYTE, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 VISTAGEN THERAPEUTICS, INC.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表のリスト
LIST OF TABLES
TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:
TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 1 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 17 CHINA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 18 CHINA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 19 CHINA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 20 CHINA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 21 CHINA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 22 CHINA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 23 CHINA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 24 CHINA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 CHINA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 CHINA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 27 CHINA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 28 CHINA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 29 CHINA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 CHINA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 JAPAN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 32 JAPAN CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 JAPAN STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 JAPAN HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 JAPAN PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 JAPAN RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 37 JAPAN INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 38 JAPAN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 JAPAN RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 JAPAN CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 JAPAN ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 JAPAN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 JAPAN STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 JAPAN STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 46 SOUTH KOREA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 47 SOUTH KOREA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 48 SOUTH KOREA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 49 SOUTH KOREA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 50 SOUTH KOREA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 51 SOUTH KOREA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 52 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 SOUTH KOREA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 SOUTH KOREA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 SOUTH KOREA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 SOUTH KOREA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 59 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 60 AUSTRALIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 61 AUSTRALIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 62 AUSTRALIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 63 AUSTRALIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 64 AUSTRALIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 65 AUSTRALIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 66 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 AUSTRALIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 AUSTRALIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 AUSTRALIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 AUSTRALIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 71 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 73 SINGAPORE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 74 SINGAPORE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 75 SINGAPORE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 76 SINGAPORE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 77 SINGAPORE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 78 SINGAPORE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 79 SINGAPORE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 80 SINGAPORE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 SINGAPORE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 SINGAPORE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 SINGAPORE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 SINGAPORE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 SINGAPORE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 SINGAPORE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 INDIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 88 INDIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 89 INDIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 90 INDIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 91 INDIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 92 INDIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 93 INDIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 94 INDIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 95 INDIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 96 INDIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 INDIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 INDIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 INDIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 INDIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 THAILAND STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 102 THAILAND CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 103 THAILAND STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 104 THAILAND HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 105 THAILAND PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 106 THAILAND RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 107 THAILAND INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 108 THAILAND STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 THAILAND RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 THAILAND ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 THAILAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 THAILAND STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 THAILAND STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 119 MALAYSIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 120 MALAYSIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 121 MALAYSIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 122 MALAYSIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 MALAYSIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 124 MALAYSIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 125 MALAYSIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 126 MALAYSIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 MALAYSIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 128 MALAYSIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 129 INDONESIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 130 INDONESIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 131 INDONESIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 132 INDONESIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 133 INDONESIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 134 INDONESIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 135 INDONESIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 136 INDONESIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 137 INDONESIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 138 INDONESIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 139 INDONESIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 140 INDONESIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 141 INDONESIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 142 INDONESIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 143 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 144 PHILIPPINES CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 145 PHILIPPINES STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 146 PHILIPPINES HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 147 PHILIPPINES PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 148 PHILIPPINES RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 149 PHILIPPINES INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 150 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 151 PHILIPPINES RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 152 PHILIPPINES CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 153 PHILIPPINES ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 154 PHILIPPINES AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 155 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 156 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 157 REST OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
図表一覧
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE ASIA-PACIFIC STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC STEM CELL MANUFACTURING MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
FIGURE 15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
FIGURE 16 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
FIGURE 17 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
FIGURE 18 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 19 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
FIGURE 20 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
FIGURE 21 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2020
FIGURE 24 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
FIGURE 25 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
FIGURE 26 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
FIGURE 28 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
FIGURE 29 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 30 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 32 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2020)
FIGURE 33 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2021 & 2028)
FIGURE 34 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2020 & 2028)
FIGURE 35 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 36 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 37 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
FIGURE 38 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 39 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 40 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 41 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
